# Analysis of the Coagulopathy Developed by COVID-19 Infected Patients

> **NCT04356950** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 175 (actual)

## Conditions studied

- Sepsis
- Blood Coagulation Disorders
- Thrombin
- Disseminated Intravascular Coagulation
- COVID-19

## Interventions

- **OTHER:** Thrombin generation test assay
- **OTHER:** Fibrin generation markers assays

## Key facts

- **NCT ID:** NCT04356950
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-28
- **Primary completion:** 2022-02-14
- **Final completion:** 2022-02-14
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2025-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04356950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04356950, "Analysis of the Coagulopathy Developed by COVID-19 Infected Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04356950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*